Veritas Financial Statements From 2010 to 2026

VRTHFDelisted Stock  USD 0  0.00  0.00%   
Veritas Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Veritas Pharma's valuation are provided below:
Veritas Pharma does not presently have any fundamental trend indicators for analysis.
Check Veritas Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veritas Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Veritas financial statements analysis is a perfect complement when working with Veritas Pharma Valuation or Volatility modules.
  
This module can also supplement various Veritas Pharma Technical models . Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Veritas Pharma Company Return On Equity Analysis

Veritas Pharma's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Veritas Pharma Return On Equity

    
  -5.67  
Most of Veritas Pharma's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Veritas Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Veritas Pharma has a Return On Equity of -5.67. This is 76.35% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.

Veritas Pharma Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Veritas Pharma's current stock value. Our valuation model uses many indicators to compare Veritas Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Veritas Pharma competition to find correlations between indicators driving Veritas Pharma's intrinsic value. More Info.
Veritas Pharma is rated fourth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Veritas Pharma's earnings, one of the primary drivers of an investment's value.

About Veritas Pharma Financial Statements

Veritas Pharma stakeholders use historical fundamental indicators, such as Veritas Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Veritas Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Veritas Pharma's assets and liabilities are reflected in the revenues and expenses on Veritas Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Veritas Pharma. Please read more on our technical analysis and fundamental analysis pages.
Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. Indigenous Bloom is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Veritas Pink Sheet

If you are still planning to invest in Veritas Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Veritas Pharma's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites